Adult Laryngopharyngeal Reflux

  • James Hartman


A computerized PubMed search of MEDLINE 1966-January 2006 was performed using the terms “laryngopharyngeal reflux” (LPR) and “supraesophageal reflux disease.” The resulting articles were combined into a first group and cross-referenced with a second group of articles using the keywords “treatment of reflux.” This process yielded 91 articles which were reviewed. Their references were manually cross-checked for any further relevant articles which yielded three additional pertinent studes. This search was reverified by cross-referencing studies that mapped to both the medical subject heading “gastroesophageal reflux” and “laryngeal disease.” All of these articles were reviewed to determine which met the following inclusion criteria: 1) distinct patient population of adults (>-18 years old) with symptoms and signs suggesting LPR, 2) intervention with a proton pump inhibitor (PPI) versus placebo, 3) outcome measured by patient questionnaire and video laryngoscopy.


Reflux Symptom Proton Pump Inhibitor Therapy Video Laryngoscopy Laryngopharyngeal Reflux Chronic Laryngitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004;131(4):342–350.CrossRefPubMedGoogle Scholar
  2. 2.
    Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Kreis GJ. Effect of pantoprazole on the course of refluxassociated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003;(5):462–467.CrossRefGoogle Scholar
  3. 3.
    Noordzij JP, Khridr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111(12):2147–2151.CrossRefPubMedGoogle Scholar
  4. 4.
    El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001;96(4):979–983.CrossRefPubMedGoogle Scholar
  5. 5.
    Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis double-blind randomised placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999; 3(3):243–246.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • James Hartman
    • 1
  1. 1.St. John’s Mercy Medical CenterDavid C. Pratt Cancer CenterSt. LouisUSA

Personalised recommendations